Literature DB >> 33211542

Ensuring Equitable Access To COVID-19 Vaccines In The US: Current System Challenges And Opportunities.

Angela K Shen1, Richard Hughes Iv2, Erica DeWald3, Sara Rosenbaum4, Amy Pisani5, Walt Orenstein6.   

Abstract

There has been a worldwide effort to accelerate the development of safe and effective vaccines for severe acute respiratory syndrome coronavirus-2. When vaccines become licensed and available broadly to the public, the final hurdle is equitable distribution and access for all who are recommended for vaccination. Frameworks and existing systems for allocation, distribution, vaccination, and monitoring for safety and effectiveness are assets of the current immunization delivery system that should be leveraged to ensure the equitable distribution and broad uptake of licensed vaccines. The system should be strengthened to address gaps in access to immunization services and to modernize the public health infrastructure. We offer five recommendations as guideposts to ensure that policies and practices at the federal, state, local, and tribal levels support equity, transparency, accountability, availability, and access to coronavirus disease 2019 vaccines.

Entities:  

Year:  2020        PMID: 33211542     DOI: 10.1377/hlthaff.2020.01554

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  10 in total

1.  Evaluation of Vaccination Strategies to Compare Efficient and Equitable Vaccine Allocation by Race and Ethnicity Across Time.

Authors:  Patricia Kipnis; Lauren Soltesz; Gabriel J Escobar; Laura Myers; Vincent X Liu
Journal:  JAMA Health Forum       Date:  2021-08-20

2.  Word2vec neural model-based techniqueto generate protein vectors for combating COVID-19: a machine learning approach.

Authors:  Toby A Adjuik; Daniel Ananey-Obiri
Journal:  Int J Inf Technol       Date:  2022-05-19

3.  COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment.

Authors:  Jagdish Khubchandani; Sushil Sharma; James H Price; Michael J Wiblishauser; Manoj Sharma; Fern J Webb
Journal:  J Community Health       Date:  2021-01-03

4.  A Shot at Inclusion: Reconsidering Categorical Exclusion of Hospice Patients from COVID Vaccine Allocation.

Authors:  Meaghann S Weaver; Cynthia M A Geppert; David J Alfandre
Journal:  J Pain Symptom Manage       Date:  2021-03-21       Impact factor: 3.612

5.  A multicriteria decision analysis framework to measure equitable healthcare access during COVID-19.

Authors:  Avipsa Roy; Bandana Kar
Journal:  J Transp Health       Date:  2022-01-10

6.  Gender, socioeconomic status, and COVID-19 vaccine hesitancy in the US: An intersectionality approach.

Authors:  Danielle Xiaodan Morales; Tyler Fox Beltran; Stephanie Alexandra Morales
Journal:  Sociol Health Illn       Date:  2022-05-02

7.  System Failure: The Geographic Distribution of Sepsis-Associated Death in the USA and Factors Contributing to the Mortality Burden of Black Communities.

Authors:  Adam M Lippert
Journal:  J Racial Ethn Health Disparities       Date:  2022-09-28

8.  Pandemic preparedness: synthetic biology and publicly funded biofoundries can rapidly accelerate response time.

Authors:  Claudia E Vickers; Paul S Freemont
Journal:  Nat Commun       Date:  2022-01-21       Impact factor: 14.919

9.  Orange County, California COVID-19 Vaccine Equity Best Practices Checklist: A Community-Centered Call to Action for Equitable Vaccination Practices.

Authors:  Kameko J Washburn; Alana M W LeBrón; Abigail S Reyes; Isabel Becerra; America Bracho; Ellen Ahn; Ana Siria Urzúa; Mary Anne Foo; Salvador Zárate; Sora Park Tanjasiri; Bernadette Boden-Albala
Journal:  Health Equity       Date:  2022-01-17

10.  COVID-19 Vaccine Hesitancy and Associated Factors among People with HIV in the United States: Findings from a National Survey.

Authors:  Roman Shrestha; Jaimie P Meyer; Sheela Shenoi; Antoine Khati; Frederick L Altice; Colleen Mistler; Lydia Aoun-Barakat; Michael Virata; Miriam Olivares; Jeffrey A Wickersham
Journal:  Vaccines (Basel)       Date:  2022-03-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.